Skip to main navigation Skip to search Skip to main content

Light-triggered doxorubicin release quantified by spatial frequency domain imaging and diffuse optical spectroscopy

  • Ulas Sunar
  • , Jeremy Kress
  • , Daniel J. Rohrbach
  • , Kevin A. Carter
  • , Dandan Luo
  • , Shuai Shao
  • , Shashikant Lele
  • , Jonathan F. Lovell
  • Wright State University
  • SUNY Buffalo
  • Roswell Park Cancer Institute

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

Chemo efficacy depends on the drug concentration at the target sites. Doxorubicin (Dox) is a common anti-cancer for many cancrers including ovarian cancer. Here we show quantification of the drug concentration of recently developed porphyin-phospholipid (PoP)-liposome encapsulated Dox using diffuse optical methods.

Original languageEnglish
Title of host publicationOptical Tomography and Spectroscopy, OTS 2016
PublisherOptica Publishing Group (formerly OSA)
Pages3
Number of pages1
ISBN (Print)9781943580101
StatePublished - Apr 18 2016
EventOptical Tomography and Spectroscopy, OTS 2016 - Fort Lauderdale, United States
Duration: Apr 25 2016Apr 28 2016

Publication series

NameOptics InfoBase Conference Papers
ISSN (Electronic)2162-2701

Conference

ConferenceOptical Tomography and Spectroscopy, OTS 2016
Country/TerritoryUnited States
CityFort Lauderdale
Period04/25/1604/28/16

Fingerprint

Dive into the research topics of 'Light-triggered doxorubicin release quantified by spatial frequency domain imaging and diffuse optical spectroscopy'. Together they form a unique fingerprint.

Cite this